New National Protocol for Hematopoietic Stem Cell Transplantation
Ukraine’s Ministry of Health has officially adopted the Medical Care Standard for Hematopoietic Stem Cell Transplantation in Adults and Children (Order No. 519, issued April 17, 2026). This landmark document is the first of its kind in the country’s history for bone marrow transplantation. It establishes uniform state-level procedures that align with international clinical protocols.
Treatment Strategy and Medical Facilities
Under the new standard, each patient’s treatment plan will be decided by a multidisciplinary team of specialists, including hematologists, anesthesiologists, geneticists, and other experts. Personalized care will be based on a comprehensive evaluation and HLA typing. The protocol also outlines the conditioning phase—preparing the body for transplant—as well as post-operative medical monitoring.
Currently, 13 medical institutions in Ukraine are authorized to perform hematopoietic stem cell transplants. Among them, three centers carry out allogeneic transplants from unrelated donors. In the first quarter of 2026 alone, Ukrainian doctors performed 126 transplant procedures, 13 of which were on children. This treatment offers a vital lifeline for patients battling leukemia, lymphoma, aplastic anemia, and severe immune deficiencies.
The approval of this new hematopoietic stem cell transplant standard marks a significant step forward for Ukraine’s healthcare system, improving the quality of care for patients with serious diseases. It not only brings national protocols in line with global best practices but also ensures a structured treatment approach that can boost recovery odds. Implementing such standards is expected to accelerate the development of transplant medicine in Ukraine and expand patient access to these critical services.
As the healthcare landscape in Ukraine evolves, the recent increase in transplant procedures by 15% during the first quarter of 2026 underscores the growing demand for advanced treatment options. This surge not only highlights the urgent need for standardized protocols like the newly approved hematopoietic stem cell transplantation guidelines but also reflects the ongoing improvements in patient care and medical capabilities across the nation.